Anteo Diagnostics Limited
(ASX:ADO)CEO Dr Geoffrey Cumming presents at the ASX Investor Series in Sydney.
Anteo Diganostics is a life sciences company which has created pioneering molecular glue called Mix&Go.
Dr Cumming discusses the technology behind the product, the company’s revenue streams, 2014 milestones and future opportunities.
